Can I appeal an EPO opposition decision?

Can I appeal an EPO opposition decison?
Can I appeal an EPO opposition decison?
ARTICLE SUMMARY

A decision of the EPO Opposition Division can be appealed by any party adversely affected, such as the patent proprietor, an opponent, or a valid intervenor. The appellant must file a notice of appeal and pay the fee within two months, submit the grounds within four months, after which the Board of Appeal conducts an independent review that may uphold, overturn, or remit the case.

authors
Authors
Related Services
Related Industries

A decision of the EPO Opposition Division (OD) can be appealed, but only by a party who took part in the opposition proceedings and is adversely affected by the decision.

Under Article 107 EPC, an appeal is restricted to “any party to proceedings adversely affected by a decision,” which means the patent proprietor, an opponent, or a valid intervenor (e.g., an assumed infringer who intervened under Article 105 EPC).  

To validly appeal, the adversely affected party must file a notice of appeal and pay the appeal fee within two months of notification of the written decision and must submit the statement of grounds of appeal within four months. The Board of Appeal will then conduct an independent judicial review of the OD’s decision, which may result in the decision being upheld, set aside, or the case being remitted back to the OD for further examination.

Related News

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

EU design law gets a digital upgrade

EU design law gets a digital upgrade

EU AI Act Article 50: New AI transparency rules

EU AI Act Article 50: New AI transparency rules

Priority patent applications for biotech and chemistry startups

Priority patent applications for biotech and chemistry startups

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

HPV-positive oropharyngeal cancer: prevention to precision treatment

HPV-positive oropharyngeal cancer: prevention to precision treatment

Winning at the EPO: Proven specialists in EPO oppositions

Winning at the EPO: Proven specialists in EPO oppositions

Protecting antibody innovations beyond composition claims

Protecting antibody innovations beyond composition claims

See All News
No items found.